XRCC4 and gastric cancer: Currently, biomarkers are used for the clinical diagnosis and prognosis in a variety of cancers, such as lung [58], breast [59,60], and gastric cancers [61,62] Therefore, XRCC4/5/6 can be used as novel diagnostic and prognostic biomarkers for LUAD.